An EFS - Early Feasibility Study - would be a small number:
So sayeth the FDA
A Pivotal study for a Medical Device would be analogous to a Phase-3 drug trial. Just what size patient cohort would be required I couldn't say.
My mug's eye view would be that 500 would be the low end of a Pivotal Study.
Informed opinions about plausible sequences to commercialsation welcomed.
P
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-33
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.00 |
Change
0.800(6.06%) |
Mkt cap ! $295.9M | |||
| Open | High | Low | Value | Volume |
| $13.08 | $14.00 | $12.84 | $202.5K | 15.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 88 | $13.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.00 | 1109 | 2 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |